TSG6‐Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model
Advanced Materials · 2024-05 · 36 (21)
DOI: 10.1002/adma.202308921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 15.04.2024. Verfasst von Huijun Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Department of Gynecology and Obstetrics, Tangdu Hospital, Clinical Research Center for Reproductive Medicine and Gyneco…. Hauptthemen laut MEDLINE: Endometrium, Fibrosis, Cell Adhesion Molecules, Hydrogels. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Social Talent Fund Support Program of Tangdu Hospital.
Abstract (Originalsprache)
Intrauterine adhesion (IUA) is characterized by the formation of fibrous scar tissue within the uterine cavity, which significantly impacts female reproductive health and even leads to infertility. Unfortunately, severe cases of IUA currently lack effective treatments. This study presents a novel approach that utilizes tumor necrosis factor‐(TNF) stimulated gene 6 (TSG6)‐modified exosomes (Exos) in conjunction with an injectable thermosensitive hydrogel (CS/GP) to mitigate the occurrence of IUA by reducing endometrium fibrosis in a mouse IUA model. This study demonstrate that TSG6‐modified Exos effectively inhibits the activation of inflammatory M1‐like macrophages during the initial stages of inflammation and maintains the balance of macrophage phenotypes (M1/M2) during the repair phase. Moreover, TSG6 inhibits the interaction between macrophages and endometrial stromal fibroblasts, thereby preventing the activation of stromal fibroblasts into myofibroblasts. Furthermore, this research indicates that CS/GP facilitates the sustained release of TSG6‐modified Exos, leading to a significant reduction in both the manifestations of IUA and the extent of endometrium fibrosis. Collectively, through the successful construction of CS/GP loaded with TSG6‐modified Exos, a reduction in the occurrence and progression of IUA is achieved by mitigating endometrium fibrosis. Consequently, this approach holds promise for the treatment of IUA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Department of Gynecology and Obstetrics, Tangdu Hospital, Clinical Research Center for Reproductive Medicine and Gynecological Endocrine Diseases of Shaanxi Province, Air Force Medical Univ…
- Department of Immunology, School of Basic Medicine, Air Force Medical University, No.169 West Changle Road, Xi'an, 710038, China.
ORCID-Profile: Huijun Sun, Xiaohong Wang
Förderung
- National Natural Science Foundation of China
- Social Talent Fund Support Program of Tangdu Hospital
Zitieren
APA
Sun, H., Dong, J., Fu, Z., Lu, X., Chen, X., Lei, H., Xiao, X., Chen, S., Lu, J., Su, D., Xiong, Y., Fang, Z., Mao, J., Chen, L., & Wang, X. (2024). TSG6‐Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model. Advanced Materials, 36(21). https://doi.org/10.1002/adma.202308921
Vancouver
Sun H, Dong J, Fu Z, Lu X, Chen X, Lei H, et al. TSG6‐Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model. Advanced Materials. 2024;36(21). doi:10.1002/adma.202308921
BibTeX
@article{Sun2024,
author = {Sun, Huijun and Dong, Jie and Fu, Zhaoyue and Lu, Xueyan and Chen, Xutao and Lei, Hui and Xiao, Xifeng and Chen, Shuqiang and Lu, Jie and Su, Danjie and Xiong, Yujing and Fang, Zheng and Mao, Jiaqin and Chen, Lihua and Wang, Xiaohong},
title = {TSG6‐Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {21},
doi = {10.1002/adma.202308921}
}
EUVIMED